Skip to content
healthcare.dev

ANTICOAGULANT SODIUM CITRATE

NDC 0338-9669, trisodium citrate dihydrate, solution, from Baxter Healthcare Corporation.

Product NDC
0338-9669
Status
Listed
Labeler
Baxter Healthcare Corporation
Dosage form
SOLUTION
Route
EXTRACORPOREAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
BN980123
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0338-9669 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRISODIUM CITRATE DIHYDRATE40 mg/mL

Pharmacologic classes

Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]

Package NDCNDC-11Package
0338-9669-0100338966901250 mL in 1 BAG (0338-9669-01)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7025a0f9-1a56-4416-a3a4-925d755aed90

Use it

Look up 0338-9669 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0338-9669 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0338-9669. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.